Insider Trading History of Rawcliffe Adrian


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Rawcliffe Adrian since year 2005. The trader's CIK number is 1555851. At the time of the last reporting, Rawcliffe Adrian was the Chief Executive Officer of Adaptimmune Therapeutics Plc . (stock ticker symbol ADAP). See this page for all insider trading activities at Adaptimmune Therapeutics Plc .


Stock purchases, sales, and option exercises reported by insider Rawcliffe Adrian since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-01-14 ADAP Adaptimmune Therapeutics Plc Sale 3,236 5.13 16,616
2020-01-06 ADAP Adaptimmune Therapeutics Plc Sale 5,900 1.20 7,080
2019-01-14 ADAP Adaptimmune Therapeutics Plc Sale 3,084 5.37 16,557
2018-03-20 ADAP Adaptimmune Therapeutics Plc Sale 600,000 1.71 1,026,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rawcliffe Adrian (Chief Executive Officer of Adaptimmune Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month